Casdin Capital, LLC Q4 2018 Filing

Filed February 13, 2019

Portfolio Value

$584.5B

Holdings

31

Report Date

Q4 2018

Filing Type

13F-HR

All Holdings (31 positions)

#StockSharesValue% PortfolioType
1
LOXO ONCOLOGY INC
360,000$50.4B8.63%
2
MYOKARDIA INC
790,000$38.6B6.60%
3
2L9BLUEPRINT MEDICINES CORP
640,000$34.5B5.90%
4
CDXSCODEXIS INC
2,025,000$33.8B5.79%
5
SPARK THERAPEUTICS INC
840,000$32.9B5.62%
6
BLUEBIRD BIO INC
330,000$32.7B5.60%
7
FATEFATE THERAPEUTICS INC
2,550,000$32.7B5.60%
8
SG7SAGE THERAPEUTICS INC
312,000$29.9B5.11%
9
BLFSBIOLIFE SOLUTIONS INC
2,428,571$29.2B5.00%
10
NVTA1EURINVITAE CORP
2,400,000$26.5B4.54%
11
ALNYALNYLAM PHARMACEUTICALS INC
355,000$25.9B4.43%
12
AGIOAGIOS PHARMACEUTICALS INC
445,000$20.5B3.51%
13
GENMARK DIAGNOSTICS INC
3,815,000$18.5B3.17%
14
AUDENTES THERAPEUTICS INC
860,000$18.3B3.14%
15
ILMNILLUMINA INC
60,000$18.0B3.08%
16
SRPTSAREPTA THERAPEUTICS INC
150,000$16.4B2.80%
17
MAGENTA THERAPEUTICS INC
2,643,317$15.1B2.58%
18
GBTUSDGLOBAL BLOOD THERAPEUTICS IN
350,000$14.4B2.46%
19
GBYSANGAMO THERAPEUTICS INC
1,080,000$12.4B2.12%
20
2JQGRITSTONE ONCOLOGY INC
720,586$11.1B1.90%
21
EVHEVOLENT HEALTH INC
550,000$11.0B1.88%
22
EDITEDITAS MEDICINE INC
480,000$10.9B1.87%
23
VYGRVOYAGER THERAPEUTICS INC
1,128,075$10.6B1.81%
24
ONCBEIGENE LTD
70,000$9.8B1.68%
25
FIXXEURHOMOLOGY MEDICINES INC
350,000$7.8B1.34%
26
CONSTELLATION PHARMCETICLS I
1,556,998$6.2B1.07%
27
IBBISHARES TR
60,000$5.8B0.99%
28
CDNACAREDX INC
200,000$5.0B0.86%
29
DNLIDENALI THERAPEUTICS INC
100,000$2.1B0.35%
30
QUOTIENT LTD
325,000$2.0B0.34%
31
NEON THERAPEUTICS INC
263,344$1.3B0.23%